RTI Surgical News and Resources

RTI Surgical, a contract development and manufacturing organisation (CDMO) specialising in tissue engineering and regenerative medicine, announced the enrolment of the first patient in its ADMIRE study. This clinical trial is designed to evaluate the safety and effectiveness of Cortiva

RTI Surgical announced the acquisition of Collagen Solutions, a global supplier of medical-grade collagen and xenograft tissue used in various therapeutic areas such as cardiac, sports medicine, and orthopaedics. The move strengthens RTI’s soft tissue portfolio, following its earlier acquisition